Trial NCT04362137; EudraCT 2020-001662-11
Publication RUXCOVID - Han MK, Lancet Rheumatol (2022) (published paper)
Primary outcome on the report: Composite of death, respiratory failure (requiring invasive mechanical ventilation), or ICU care, by day 29

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.